HealthReveal, the developer of an analytics platform that monitors the conditions of chronic disease sufferers, has secured $10.8m in a round led by GE Ventures.
GE Ventures, the corporate venturing vehicle for industrial conglomerate General Electric, led a $10.8m series A round for US-based healthcare technology producer HealthReveal on Thursday.
The round also featured Manatt Ventures, the venture capital arm of law firm Manatt, Phelps & Philips, as well as VC firms Greycroft Partners and Flare Capital Partners.
HealthReveal has created a cloud-based clinical analytics platform that aims to predict and mitigate potentially life threatening medical issues in patients with chronic conditions.
The software continuously…